Latest Industry Insights
Industry Insight
Beyond Mutations: Inside Immuto’s Quest To Decode Disease Structure
Immuto Scientific’s structural surfaceomics platform reveals how wild-type proteins adopt disease-specific shapes that drive pathology. Immuto identifies previously invisible drug targets and designs conformation-selective therapies.
Industry Insight
AI-Powered Platforms Are Making Complex Data Usable for Drug Discovery
In this interview, we explore how Sonrai is advancing reproducible science, enabling cross-disciplinary collaboration and shaping the future of AI-powered drug discovery.
Industry Insight
Mapping the South Korean Genome for Global Precision Medicine
Technology Networks spoke with Dr. Mark Van Oene, chief operating officer at PacBio, about an ambitious population genomics effort – the Korean Pangenome Reference Project.
Industry Insight
Redefining Large-Scale Genomics for the Future of Medicine
At this year’s American Society of Human Genetics (ASHG) meeting, Ultima Genomics drew attention for its ambitious goal of making large-scale omics research more accessible and affordable.
Industry Insight
Multiplex ddPCR Offers New Precision for Gene Expression Analysis
In this Q&A, Pratt discusses a recent study comparing multiplex droplet digital PCR (ddPCR) with traditional quantitative PCR (qPCR), highlighting key methodological differences, assay validation strategies and the advantages of ddPCR.
Industry Insight
Illumina’s Constellation and 5-Base Unlock New Depths of DNA Insights
At ASHG, Illumina launches 5-base and shows exciting results from constellation, a breakthrough technology offering long-range genomic insights from unfragmented DNA.
Industry Insight
How AI Is Accelerating the Digital Transformation of Pathology
Technology Networks spoke with Dr. Olga Colgan and Dr. Joseph Chiweshe to learn how AI-driven digital pathology is reshaping diagnostic workflows.
Industry Insight
Circular RNA: The Next Frontier for RNA Therapeutics?
Discover how circular RNA and targeted delivery technologies are advancing RNA therapeutics for chronic diseases and vaccines.
Industry Insight
How Biotech Startups Are Redefining 3D Models and Sustainability in Drug Discovery
Explore how biotech start-ups are using 3D models and automation to reduce animal testing, cut waste and improve drug discovery outcomes.
Industry Insight
Can Patients Trust a Drug Designed By AI?
Patient trust is vital as AI transforms pharma and drug discovery. Discover how transparency and regulation are making innovation safer.
Advertisement